Literature DB >> 34272866

Enhanced lateral flow testing strategies in care homes are associated with poor adherence and were insufficient to prevent COVID-19 outbreaks: results from a mixed methods implementation study.

John S P Tulloch1, Massimo Micocci2, Peter Buckle2, Karen Lawrenson3, Patrick Kierkegaard2,4, Anna McLister2, Adam L Gordon5,6, Marta García-Fiñana7, Steve Peddie8, Matthew Ashton3, Iain Buchan7, Paula Parvulescu3.   

Abstract

INTRODUCTION: Care homes have been severely affected by the SARS-CoV-2 pandemic. Rapid antigen testing could identify most SARS-CoV-2 infected staff and visitors before they enter homes. We explored implementation of staff and visitor testing protocols using lateral flow devices (LFDs).
METHODS: An evaluation of a SARS-CoV-2 LFD-based testing protocol in 11 care homes in Liverpool, UK, including staff and visitor testing, plus a qualitative exploratory study in nine of these homes. The proportion of pilot homes with outbreaks, and outbreak size, were compared to non-pilot homes in Liverpool. Adherence to testing protocols was evaluated. Fifteen staff were interviewed, and transcript data were thematically coded using an iterative analysis to identify and categorize factors influencing testing implementation.
RESULTS: In total, 1,638 LFD rapid tests were performed on 407 staff. Protocol adherence was poor with 8.6% of staff achieving >75% protocol adherence, and 25.3% achieving $\ge$50%. Six care homes had outbreaks during the study. Compared to non-pilot care homes, there was no evidence of significant difference in the proportion of homes with outbreaks, or the size of outbreaks. Qualitative data showed difficulty implementing testing strategies due to excessive work burden. Factors influencing adherence related to test integration and procedural factors, socio-economic factors, cognitive overload and the emotional value of testing.
CONCLUSION: Implementation of staff and visitor care home LFD testing protocols was poorly adhered to and consequently did not reduce the number or scale of COVID-19 outbreaks. More focus is needed on the contextual and behavioural factors that influence protocol adherence.
© The Author(s) 2021. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; antigen test; care homes; lateral flow devices; rapid point-of-care testing

Mesh:

Year:  2021        PMID: 34272866      PMCID: PMC8406873          DOI: 10.1093/ageing/afab162

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  11 in total

1.  Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups.

Authors:  Allison Tong; Peter Sainsbury; Jonathan Craig
Journal:  Int J Qual Health Care       Date:  2007-09-14       Impact factor: 2.038

2.  Methods of data collection in qualitative research: interviews and focus groups.

Authors:  P Gill; K Stewart; E Treasure; B Chadwick
Journal:  Br Dent J       Date:  2008-03-22       Impact factor: 1.626

3.  COVID-19 testing in outbreak-free care homes: what are the public health benefits?

Authors:  R Green; J S P Tulloch; C Tunnah; E Coffey; K Lawrenson; A Fox; J Mason; R Barnett; A Constantine; W Shepherd; M Ashton; M B J Beadsworth; R Vivancos; I Hall; N Walker; S Ghebrehewet
Journal:  J Hosp Infect       Date:  2021-01-13       Impact factor: 3.926

4.  SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis.

Authors:  Muge Cevik; Matthew Tate; Ollie Lloyd; Alberto Enrico Maraolo; Jenna Schafers; Antonia Ho
Journal:  Lancet Microbe       Date:  2020-11-19

5.  COVID-19 testing in English care homes and implications for staff and residents.

Authors:  Massimo Micocci; Adam L Gordon; A Joy Allen; Timothy Hicks; Patrick Kierkegaard; Anna McLister; Simon Walne; Gail Hayward; Peter Buckle
Journal:  Age Ageing       Date:  2021-05-05       Impact factor: 10.668

Review 6.  Commercialized diagnostic technologies to combat SARS-CoV2: Advantages and disadvantages.

Authors:  Briza Pérez-López; Mònica Mir
Journal:  Talanta       Date:  2020-12-03       Impact factor: 6.556

7.  Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19.

Authors:  Michael J Mina; Tim E Peto; Marta García-Fiñana; Malcolm G Semple; Iain E Buchan
Journal:  Lancet       Date:  2021-02-17       Impact factor: 79.321

8.  COVID-19 point-of-care testing in care homes: what are the lessons for policy and practice?

Authors:  Peter Buckle; Massimo Micocci; John Tulloch; Patrick Kierkegaard; Paula Parvulescu; Carl Thompson; Karen Spilsbury; A Joy Allen; Richard Body; Gail Hayward; Iain Buchan; Adam L Gordon
Journal:  Age Ageing       Date:  2021-05-12       Impact factor: 10.668

9.  Performance of the Innova SARS-CoV-2 antigen rapid lateral flow test in the Liverpool asymptomatic testing pilot: population based cohort study.

Authors:  Marta García-Fiñana; David M Hughes; Christopher P Cheyne; Girvan Burnside; Mark Stockbridge; Tom A Fowler; Veronica L Fowler; Mark H Wilcox; Malcolm G Semple; Iain Buchan
Journal:  BMJ       Date:  2021-07-06
View more
  8 in total

Review 1.  Diagnoses Based on C-Reactive Protein Point-of-Care Tests.

Authors:  Miroslav Pohanka
Journal:  Biosensors (Basel)       Date:  2022-05-17

Review 2.  Non-pharmacological measures implemented in the setting of long-term care facilities to prevent SARS-CoV-2 infections and their consequences: a rapid review.

Authors:  Jan M Stratil; Renke L Biallas; Jacob Burns; Laura Arnold; Karin Geffert; Angela M Kunzler; Ina Monsef; Julia Stadelmaier; Katharina Wabnitz; Tim Litwin; Clemens Kreutz; Anna Helen Boger; Saskia Lindner; Ben Verboom; Stephan Voss; Ani Movsisyan
Journal:  Cochrane Database Syst Rev       Date:  2021-09-15

3.  Strategies to implement SARS-CoV-2 point-of-care testing into primary care settings: a qualitative secondary analysis guided by the Behaviour Change Wheel.

Authors:  Patrick Kierkegaard; Timothy Hicks; A Joy Allen; Yaling Yang; Gail Hayward; Margaret Glogowska; Brian D Nicholson; Peter Buckle
Journal:  Implement Sci Commun       Date:  2021-12-18

4.  Rapid antigen testing as a reactive response to surges in nosocomial SARS-CoV-2 outbreak risk.

Authors:  David R M Smith; Audrey Duval; Jean Ralph Zahar; Lulla Opatowski; Laura Temime
Journal:  Nat Commun       Date:  2022-01-11       Impact factor: 14.919

5.  Agent-based simulations for protecting nursing homes with prevention and vaccination strategies.

Authors:  Jana Lasser; Johannes Zuber; Johannes Sorger; Elma Dervic; Katharina Ledebur; Simon David Lindner; Elisabeth Klager; Maria Kletečka-Pulker; Harald Willschke; Katrin Stangl; Sarah Stadtmann; Christian Haslinger; Peter Klimek; Thomas Wochele-Thoma
Journal:  J R Soc Interface       Date:  2021-12-22       Impact factor: 4.118

6.  Exploration of the uptake of asymptomatic COVID-19 lateral flow testing in Birmingham, UK: survey and qualitative research.

Authors:  Jonathan Mathers; Christopher Poyner; Dean Thompson; Gavin Rudge; Ruth V Pritchett
Journal:  BMJ Open       Date:  2022-04-20       Impact factor: 3.006

Review 7.  Effectiveness of rapid antigen testing for screening of asymptomatic individuals to limit the transmission of SARS-CoV-2: A rapid review.

Authors:  Kieran A Walsh; Natasha Broderick; Susan Ahern; Christopher G Fawsitt; Katie M O'Brien; Marie Carrigan; Patricia Harrington; Michelle O'Neill; Susan M Smith; Susan Spillane; Conor Teljeur; Máirín Ryan
Journal:  Rev Med Virol       Date:  2022-03-29       Impact factor: 11.043

8.  Daily testing of contacts of SARS-CoV-2 infected cases as an alternative to quarantine for key workers in Liverpool: A prospective cohort study.

Authors:  Lucy Marsden; David M Hughes; Rhiannon Corcoran; Christopher P Cheyne; Matt Ashton; Iain Buchan; Emer Coffey; Marta García-Fiñana
Journal:  EClinicalMedicine       Date:  2022-07-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.